Mice with IL-33 deficiency in the ALI model exhibited higher mortality and more severe lung pathology (p < 0.05); supplementation with recombinant IL-33 protein significantly reduced IL-6, G-CSF, and MCP-1 levels in BALF and restored immune balance (p < 0.01). Here, IL6 is linked to acute respiratory distress syndrome.